Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03113461 · ClinicalTrials.gov registry record · NA

MCI: CPAP Treatment of OSA (Memories2)

A NA study of Mild Cognitive Impairment and Sleep Apnea, Obstructive, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
327
Enrollment target
4
Study locations

NCT03113461: Active NA study of Mild Cognitive Impairment and Sleep Apnea, Obstructive, sponsored by University of Pennsylvania.

NCT03113461 is a NA study of Mild Cognitive Impairment and Sleep Apnea, Obstructive that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 327 participants, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03113461, a NA study of Mild Cognitive Impairment and Sleep Apnea, Obstructive, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
327 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this project is to determine whether obstructive sleep apnea (OSA) treatment with positive airway pressure therapy (CPAP) can delay the progression of cognitive impairment in patients with amnestic Mild Cognitive Impairment (MCI) as measured by cognitive testing, and brain magnetic resonance imaging (MRI) scans. Study participants will be assessed at baseline, six-month (cognitive tests only) and one-year follow-up.

Conditions Studied

Mild Cognitive Impairment Sleep Apnea, Obstructive

Interventions

  • DEVICE CPAP

Study Locations (4)

Missouri

  • Washington University in St. Louis - St Louis

Pennsylvania

  • University of Pennsylvania - Philadelphia

Texas

  • University of Texas at Austin - Austin

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 327 participants
Start Date 2018-01-19
Est. Completion 2025-07-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03113461

The ClinicalTrials.gov registry entry for NCT03113461 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (74% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which CPAP is the first listed.

NCT03113461 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Missouri, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT03113461 about?

NCT03113461 is a clinical study titled "MCI: CPAP Treatment of OSA (Memories2)". The purpose of this project is to determine whether obstructive sleep apnea (OSA) treatment with positive airway pressure therapy (CPAP) can delay the progression of cognitive impairment in patients with amnestic Mild Cognitive Impairment (MCI) as measured by cognitive testing, and brain magnetic re...

What is the current status of trial NCT03113461?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 327 participants. The study started on 2018-01-19. Estimated completion is 2025-07-01.

What conditions does trial NCT03113461 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Sleep Apnea, Obstructive.

What interventions are being tested in trial NCT03113461?

The interventions under investigation include: CPAP (DEVICE).

Who is sponsoring clinical trial NCT03113461?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03113461 being conducted?

This trial has 4 study locations across Missouri, Pennsylvania, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment

All registered trials for this condition

Sleep Apnea, Obstructive

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.